A prospective study of circulating adipokine levels and risk of multiple myeloma

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

(2011) J. A. Fowler et al.   BLOOD

Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies

(2011) Alice Wallin et al.   EUROPEAN JOURNAL OF CANCER

Associations Between Anthropometry, Cigarette Smoking, Alcohol Consumption, and Non-Hodgkin Lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

(2010) Jesse D. Troy et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Biological Mechanisms Linking Obesity and Cancer Risk: New Perspectives

(2010) Darren L. Roberts et al.   Annual Review of Medicine

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

(2010) O. Landgren et al.   BLOOD

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation

(2010) A C Sprynski et al.   LEUKEMIA

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

(2009) Anne Catherine Sprynski et al.   BLOOD

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

Obesity and Cancer: The Role of Dysfunctional Adipose Tissue

(2009) R. C.M. van Kruijsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study

(2008) Maria Dalamaga et al.   CANCER CAUSES & CONTROL